Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$6,820,000
Lobbying expense
—
Federal awards
—
Relationships
47
| $170,000 |
| — |
| lobbied by | Orchard Therapeutics North America | $170,000 | — |
| lobbied by | Inc. Ionis Pharmaceuticals | $160,000 | — |
| lobbied by | Incyte Corporation | $140,000 | — |
| lobbied by | Inc. Neuropace | $130,000 | — |
| lobbied by | Inc. Ptc Therapeutics | $130,000 | — |
| lobbied by | Glaxosmithkline Llc | $120,000 | — |
| lobbied by | Avadel Pharmaceuticals Plc | $120,000 | — |
| lobbied by | Stealth Biotherapeutics Inc. | $120,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Regenxbio Inc. | $120,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $120,000 | — |
| lobbied by | Avadel Pharmaceuticals Plc | $120,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Inc. Alkermes | $120,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Regenxbio Inc. | $120,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Savara Inc. | $120,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Glaxosmithkline Llc | $100,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Stealth Biotherapeutics Inc. | $100,000 | — |
| lobbied by | Incyte Corporation | $100,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Inc. Ptc Therapeutics | $100,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Erisa Industry Committee (eric) | $100,000 | — |
| lobbied by | Harmony Biosciences | $100,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Alnylam Pharmaceuticals, Inc. | $100,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Medical Device Manufacturers Association | $80,000 | — |
| lobbied by | Acadia Pharmaceuticals | $70,000 | — |
| lobbied by | Medical Device Manufacturers Association | $70,000 | — |
| lobbied by | Inc Neurocrine Biosciences | $70,000 | — |
| lobbied by | Biomarin Pharmaceutical Inc. | $70,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $70,000 | — |
| lobbied by | Ardelyx Inc | $60,000 | — |
| lobbied by | Inc. Exelixis | $60,000 | — |
| lobbied by | Harmony Biosciences | $60,000 | — |
| lobbied by | Inc. Neuropace | $60,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $60,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Inc. Ionis Pharmaceuticals | $60,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Erisa Industry Committee (eric) | $60,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Ardelyx Inc | $60,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Orchard Therapeutics North America | $50,000 | — |
| lobbied by | Inc. Travere Therapeutics | $50,000 | — |
| lobbied by | Inc. Ionis Pharmaceuticals | $40,000 | — |
| lobbied by | Rare Disease Company Coalition | $40,000 | — |
| lobbied by | Medical Device Manufacturers Association | $40,000 | Apr 17, 2026 – Jul 5, 2026 |
| lobbied by | Inc. Travere Therapeutics | $30,000 | Apr 17, 2026 – Apr 17, 2026 |
| lobbied by | Savara Inc. | $30,000 | — |
| employed by | Alanna Temme | 1 | — |